Metraipolis › archive › dc_cd31d80f0de8

Hydroxysafflor Yellow A improves diabetic nephropathy by inhibiting PI3K/AKT/mTOR pathway based on a multidimensional study — Europe PMC PMID:41704706

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41704706
DOI
10.3389/fmed.2026.1747346
License (as archived)
solo-consultazione
Archived
2026-11-06T04:34:17.672Z
SHA-256 of the archived text
445a1b6e01b801c23d1eee75e99ef8e2900a1fe021290c5b654625665049012e
Stable URL of this page
https://metraipolis.com/documento/dc_cd31d80f0de8

How to cite

Hydroxysafflor Yellow A improves diabetic nephropathy by inhibiting PI3K/AKT/mTOR pathway based on a multidimensional study — Europe PMC PMID:41704706 — Europe PMC (en), https://europepmc.org/article/MED/41704706 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd31d80f0de8 (Metraipolis archive dc_cd31d80f0de8, sha256 445a1b6e01b801c23d1eee75e99ef8e2900a1fe021290c5b654625665049012e)
BibTeX
@misc{dccd31d80f0de8,
  title = {Hydroxysafflor Yellow A improves diabetic nephropathy by inhibiting PI3K/AKT/mTOR pathway based on a multidimensional study — Europe PMC PMID:41704706},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41704706},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd31d80f0de8; sha256 445a1b6e01b801c23d1eee75e99ef8e2900a1fe021290c5b654625665049012e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41704706. Agents can read the archived copy with the MCP tool read_document.